Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07603739 · ClinicalTrials.gov registry record · NA
Eating Almonds Before a Meal to Control Blood Sugar
A NA study, sponsored by Pennington Biomedical Research Center.
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07603739: Clinical Trial NA study, sponsored by Pennington Biomedical Research Center.
NCT07603739 is a NA study that has not yet begun recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07603739, a NA study, has not yet begun recruiting, sponsored by Pennington Biomedical Research Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of this study is to learn whether eating a small serving of almonds before meals can improve blood sugar control in adults who have early signs of problems with blood sugar regulation. The main questions it aims to answer are: 1. Does eating almonds before a meal reduce the rise in blood sugar after eating? 2. Do some people consistently benefit more than others from eating almonds before meals?
Primary Outcome
The primary endpoint will be the difference in plasma glucose incremental area under the curve (iAUC) assessed via intravenous blood sampling over three hours following a standardized mixed meal tolerance test (MMTT) with premeal ingestion of 18 g of almonds 30 minutes prior (MMTT+) compared to without (MMTT-). This effect will be averaged across the replicated acute challenge visits in the repeated crossover design.
Interventions
- DIETARY_SUPPLEMENT Premeal almond ingestion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-07 |
| Phase | NA |
What is known before NCT07603739 opens enrollment
NCT07603739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Premeal almond ingestion is the first listed.
NCT07603739 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07603739 about?
NCT07603739 is a clinical study titled "Eating Almonds Before a Meal to Control Blood Sugar". The goal of this study is to learn whether eating a small serving of almonds before meals can improve blood sugar control in adults who have early signs of problems with blood sugar regulation. The main questions it aims to answer are: 1. Does eating almonds before a meal reduce the rise in blood s...
What is the current status of trial NCT07603739?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-06. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07603739?
The interventions under investigation include: Premeal almond ingestion (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07603739?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07603739's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia